NYSE - Delayed Quote USD

CONMED Corporation (CNMD)

70.01 -1.30 (-1.82%)
At close: April 24 at 4:00 PM EDT
68.00 -2.01 (-2.87%)
Pre-Market: 4:09 AM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Curt R. Hartman Chairman of the Board, CEO & President 2.45M -- 1964
Mr. Todd W. Garner Executive VP of Finance & CFO 1.17M 1.21M 1969
Ms. Heather L. Cohen Executive VP, Chief Human Resources & Legal Officer and Secretary 820.47k 463.2k 1973
Mr. Patrick J. Beyer President of International & Global Orthopedics 1.6M -- 1966
Mr. Stanley W. Peters III President of Advanced Surgical & Advanced Endoscopic Technologies 897.08k 1.04M 1975
Mr. Peter K. Shagory Executive Vice President of Strategy & Corporate Development -- -- 1969
Ms. Shanna L. Cotti-Osmanski Executive VP of Information Technology & CIO -- -- 1977
Mr. John Ferrell Executive Vice President of Human Resources -- -- 1968
Mr. Daniel S. Jonas Esq. Special Counsel & Corporate Secretary 646.48k 3.51M 1964
Mr. David R. Murray President of ConMed Electrosurgery 469.17k -- 1948

CONMED Corporation

11311 Concept Boulevard
Largo, FL 33773-4908
United States
727 392 6464 https://www.conmed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
4,000

Description

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Corporate Governance

CONMED Corporation’s ISS Governance QualityScore as of April 1, 2024 is 3. The pillar scores are Audit: 3; Board: 4; Shareholder Rights: 3; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 24, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Apr 08, 2024
    ARS: Annual Report to Shareholders
    See Full Filing
  • Apr 05, 2024
    Dividend Date
  • Mar 14, 2024
    Ex-Dividend Date
  • Feb 28, 2024
    10-K: Periodic Financial Reports
    See Full Filing

Upcoming Events

Jul 24, 2024 - Jul 29, 2024
CONMED Corporation Earnings Call

Related Tickers